Chlorination of epithelial tight junction proteins by neutrophil myeloperoxidase promotes barrier dysfunction and

Ian M Cartwright1,2,3, Liheng Zhou1,2, Samuel D Koch1,2

  • 1Mucosal Inflammation Program and.

JCI Insight
|August 12, 2024
PubMed

Insights

Blocking myeloperoxidase (MPO) in neutrophils reduces colitis severity and preserves intestinal barrier function. MPO deficiency limits tissue damage, offering a potential therapeutic target for inflammatory bowel diseases.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Neutrophils, including polymorphonuclear leukocytes (PMNs), are key immune cells in mucosal inflammation.
  • The neutrophil enzyme myeloperoxidase (MPO) aids microbial clearance but can cause bystander tissue damage.

Purpose of the Study:

  • To investigate the role of MPO in acute and chronic colitis.
  • To determine if blocking MPO can attenuate colitis and preserve intestinal barrier function.

Main Methods:

  • Utilized dextran sodium sulfate (DSS) model for acute and chronic murine colitis.
  • Compared MPO-deficient mice with wild-type controls.
  • Analyzed intestinal epithelial barrier function and tight junction protein regulation.
  • Validated findings in human ulcerative colitis biopsies.

Main Results:

  • MPO-deficient mice showed reduced inflammation and faster colitis resolution.
  • Activated MPO disrupted intestinal epithelial barrier function by dysregulating tight junction proteins.
  • MPO chlorinates tyrosine residues in tight junction proteins, causing mislocalization and dysfunction.
  • Human ulcerative colitis biopsies correlated disease severity with elevated chlorinated tyrosine levels.

Conclusions:

  • MPO contributes to bystander tissue damage and barrier dysfunction in colitis.
  • Targeting MPO may be a viable therapeutic strategy for inflammatory bowel diseases.
  • Preserving mucosal barrier function is crucial for managing intestinal inflammation.

Related Concept Videos

Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
5.2K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
557
Adherens Junctions01:24

Adherens Junctions

Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types –  adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as  epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as  heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
4.7K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
362
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
342